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Abstract
Microvascular ischemia and infections are associated with the
development of chronic rejection following lung transplantation.
The vonHippel–Lindau protein (VHL) controls protein levels of
hypoxia-inducible factors (HIFs), regulates vascular repair, and
improves tissue perfusion. Here, we studied the role of VHL in
microvascular repair by orthotopically transplanting tracheas
into mice with VHL haplodeficiency in Tie2 lineage cells. We
showed that VHL haplodeficiency prolonged airway microvas-
cular perfusion and promoted tissue blood flow through the
production of the angiogenic factors, SDF-1 and angiopoietin
1. VHL-haplodeficient pulmonary endothelial cells exhibited
increased angiogenic activity, resistance to serum deprivation-
induced cell death, and enhanced microvascular repair. By
contrast, in recipient mice with HIF-1α deficiency in Tie2
lineage cells, microvascular repair was significantly diminished
and suggested that recipient-derived HIF-1α normally partici-
pates in the repair of alloimmune-mediated microvascular dam-
age. To evaluate the translational impact of our findings, we
compared VHL-haplodeficient mice with wild-type controls
using a model of Aspergillus airway infection. In 83 % of the
VHL-haplodeficient recipients, Aspergillus fumigatus was non-
invasive in contrast to 75% ofwild-typemice in which themold
was deeply invasive. Our study demonstrated that stabilization
of HIF-1α in angiogenic cells, through Tie2 cell VHL
haplodeficiency, promoted airway microvascular regeneration
and vascular normalization and thereby minimized tissue ische-
mia and hypoxia. By also mitigating the virulence of A.
fumigatus, a common pathogen and itself a risk factor for the
development of lung transplant rejection, the selective enhance-
ment of HIF-1α expression has the prospect of offering several
novel therapeutic effects to transplant recipients.
Key message
& Microvascular loss and prolonged ischemia occurs with
acute rejection.
& Von Hippel-Lindau (VHL) protein controls hypoxia in-
ducible factors (HIFs).
& In tracheal allografts, VHL haplodeficient Tie2 cells
promote neovascularization.
& Reduced transplant ischemia limits Aspergillus invasion.
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Introduction
The main obstacle for long-term survival of lung transplant
recipients is chronic rejection, histologically manifested as
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obliterative bronchiolitis (OB). Yet, the mechanisms by
which OB develops remain poorly understood [1]. Recent
autopsy studies have shown that airway microcirculatory dys-
function and ensuing small airway ischemia precede the onset
of OB [2, 3]. Infections after lung transplantation also con-
tribute to the development of OB [4]. Among these pathogens,
infection with Aspergillus fumigatus results in a variety of
diseases including: Aspergillus colonization, which contrib-
utes to OB, airway anastomotic infections, and invasive pul-
monary aspergillosis [4–6]. For lung transplant recipients,
infection with A. fumigatus represents a major cause of mor-
bidity, with mortality rates as high as 82 % [5–8]. In addition
to the pathogen’s putative role in chronic rejection, ischemic
areas also may provide a substrate for fungal growth because
A. fumigatus derives its nourishment from decaying organic
matter. Thus, microvascular injury may be a central factor for
the development of OB by promoting chronic allograft rejec-
tion and by fostering infections with OB-inducing microor-
ganisms such as A. fumigatus.
In a murine orthotopic tracheal transplantation (OTT)
model, we found that airway microvascular injury with as-
sociated tissue ischemia and hypoxia is apparent during
acute rejection, which is followed by vascular regeneration
and remodeling [9]. We further demonstrated that enhancing
microvascular integrity during the acute phase of rejection
preserved the airway architecture and attenuated chronic
rejection [10]. How damaged airway microvasculature is
repaired and regenerated during rejection episodes is incom-
pletely understood. Additionally, it is not known whether
enhanced airway microvascular regeneration can be
achieved through augmenting the functional capacity of
recipient-derived angiogenic cells and what role modulating
microvascular ischemia may play in pathogen virulence.
The VHL gene encodes a multifunctional protein, pVHL,
the substrate-binding subunit of an E3 ubiquitin ligase, which
plays an important role in oxygen-sensing pathways by regu-
lating the degradation of hypoxia-inducible factor (HIF)-1α
subunit [11]. In the presence of oxygen, two proline residues
of HIF-1α are hydroxylated by the prolyl hydroxylase PHD2,
facilitating pVHL complex binding, to direct proteasomal
degradation of HIF-1α. In hypoxic conditions, PHD2 is inac-
tive and HIF-1α is stabilized. HIF-1α then dimerizes with the
β subunit, translocates to the nucleus, and induces gene tran-
scription through binding to hypoxia response elements on
enhancers of the oxygen-sensitive genes [12].
In the OTT model, damaged airway microvasculature is
repaired by recipient-derived Tie2-expressing cells, com-
prised of three major subpopulations: cells of endothelial
lineage, Tie2-expressing monocytes (TEM) of myeloid ori-
gin, and pericyte precursors of mesenchymal derivation [10].
HIF-1α stabilization by adenosine-mediated signaling in-
creases cellular adaptation to ischemic conditions [13]. In a
mouse hind limb ischemia model, HIF-1α gene therapy
increased homing of bone marrow-derived angiogenic cells
(BMDACs); combined with the induction of HIF-1α in
BMDACs, which promoted BMDAC survival in ischemic
areas, this approach synergistically enhanced revasculariza-
tion [14, 15]. Endothelial cell (EC) PHD2 haplodeficiency
normalizes tumor microvasculature structure and diminishes
metastasis [16]. Together these studies suggest that increas-
ing HIF expression in angiogenic cells promotes vascular
repair and tissue normoxia.
We subsequently hypothesized that increasing HIF-1α
expression in Tie2-expressing cells would enhance airway
microvascular regeneration. To achieve this, we specifically
knocked down VHL in Tie2 lineage cells and examined how
VHL haplodeficiency altered airway microvascular repair.
We then evaluated the translational impact of increased tis-
sue vascularization, using a model of Aspergillus tracheal
infection. The main objective of this study was to determine
whether airway microvascular repair and regeneration could
be enhanced through increased expression of HIF-1α in
recipient-derived angiogenic cells and if this effect would
modify the A. fumigatus host–pathogen interaction.
Materials and methods
Mice
All animal procedures were approved by Stanford’s Admin-
istrative Panel on Laboratory Animal Care and/or the VA Palo
Alto Institutional Animal Care and Utilization Committee. In
addition, the Stanford University Applied Panel on Biosafety
(protocol number 1007-MN0312) approved all microbiologi-
cal experiments performed in this study. All mice including
C57BL/6J (B6; H-2b), Balb/c (H-2d), C; 129S-Vhltm1Jae/J,
B6.Cg-Tg (Tek-cre)12Flv/J; and B6.129-Hif1atm3Rsjo/J
were purchased from the Jackson Laboratory.
To create VHL haplodeficiency in Tie2 lineage cells, mice
with loxP sites on both sides of exon 1 of the VHL gene
(VHLloxP/loxP) were crossed with mice expressing Cre under
promoter Tie2 (Tie2Cre mice). Tie2Cre(−)VHL(fl/+) were used
as control and Tie2Cre(+)VHL(fl/+) mice as Tie2 lineage VHL
haplodeficiency. For HIf-1α knockout in Tie2 lineage cells,
mice with HIF-1α exon 2 floxed (HIF-1αloxP/loxP) were also
crossed with Tie2Cre mice. Tie2Cre(−)HIF1α(fl/fl) mice were
used as control and Tie2Cre(+)HIF1α(fl/fl) as Tie2 lineage HIF-
1α knockout. Those mice were used as transplant recipients.
Tracheal transplantation
Balb/c mice were used as donors. Mice with transgenes as
described above were used as recipients. Basic surgical pro-
cedures of tracheal transplantation were carried out as previ-
ously described [10]. Briefly, both donor and recipient mice
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were anesthetized with 50 mg/kg ketamine and 10 mg/kg
xylazine. Five- to seven-ring tracheal segments were re-
moved from donor mice that were matched for recipient
age and sex. The donor tracheas were stored in PBS on ice
before transplantation. A short incision was made in the
midline of the neck region of the recipient. The strap muscles
were then bluntly divided and pulled aside by a 3-0 suture,
which allowed clear exposure of the laryngotracheal com-
plex. After the recipient trachea was transected, donor tra-
chea was sewn in with 10-0 nylon sutures, and the skin was
closed with 5-0 silk sutures.
A. fumigatus airway infection model
A. fumigatus, 10AF (ATCC 90240), was used for all infec-
tions. Cultures were revived from long-term storage at
−80 °C by growth at 37 °C on potato dextrose agar. Conidia
were harvested by washing the surface of the agar plate with
0.05 % Tween 80 in saline (vol/vol). Viability was assessed
by quantitative plating of serial dilutions of the conidia onto
Sabouraud dextrose agar plates. These were incubated for
48 h at 37 °C and the number of colonies counted. The
suspension was then diluted to a concentration of 3–4×108
conidia per ml. Prior to infection, conidia were centrifuged
(5,000×g for 5 min) and then washed twice with 1× PBS
after centrifugation to remove excess Tween. Inoculation
occurred via intratracheal injection (29-gauge insulin syrin-
ge), in which a 40-μl conidial solution was injected to two
tracheal rings rostral to the cephalad anastomosis. After
inoculation, animals were administered triamcinolone
acetonide (40 mg/kg) subcutaneously. At day 2 after infec-
tion, all surviving mice were euthanatized using CO2
asphyxia.
Tissue preparation for perfusion studies
and immunohistochemistry
For whole-mount tracheal microvascular analysis, mice were
injected with 100 μl of FITC-conjugated tomato lectin (Vec-
tor Laboratories) at a concentration of 1 mg/ml. After 5 min
of circulation, mice were perfused with 1 % paraformalde-
hyde (PFA) diluted in PBS for about 2 min until the outflow
of the solution turned clear. The tracheas were then
harvested, put in 1 % PFA for 1 h at 4 °C, and washed three
times with PBS. Whole tracheas were mounted on glass
slides in Vectashield H-1200 mounting medium (Vector
Laboratories). Blood perfusion unit measurement was car-
ried out as described [17]. For assessment of the percentage
of the perfused area, we examined the whole tracheal allo-
graft (every cartilaginous and intercartilaginous region),
each perfused area received a score of 1 and each non-
perfused area received a score of 0. The percentage was then
calculated as follows: total score/total regions examined.
Frozen sections were used for other immunohistochemistry
analysis. Trachea samples were snap-frozen in optimal cut-
ting temperature (OCT) solution (Sakura Finetek) after har-
vest, and OCT-embedded samples were stored at −80 °C.
Eight-micrometer sections were used for immunofluores-
cence staining. Anti-CD31 (1:200; BD Pharmingen) anti-
body was used to stain endothelial cells; anti-desmin
(1:200; Millipore) antibody was used to stain pericytes; and
anti-CD4 (1:200) and anti-CD8 (1:200; BD Pharmingen)
were used to stain CD4+ and CD8+ T cells, respectively.
Photomicrographs were taken with a Zeiss LSM 510 laser
scanning confocal microscope with Zeiss LSM Image
Browser software.
Lung EC isolation and culture, Matrigel assay, scratch assay,
and cell death assay
Mouse endothelial cell isolation Dynabeads®Sheep (1×107)
were coated with anti-rat IgG (Invitrogen, cat. 110.35) then
mixed with 1.5 μg rat anti-mouse monoclonal CD31 IgG
(BD Pharmingen). The beads and antibody were incubated
at 2–8 °C overnight. Mouse lung tissues were minced into
1–2 mm pieces and then digested by adding 10 ml of
1 mg/ml collagenase (Sigma) at 37 °C for 1 h. The cells
were filtered through sterile 70 μm nylon mesh and washed
twice with 1× PBS. Coated Dynabeads® were added to
cells and incubated for 30 min at 4 °C to allow binding to
cells. The cells were washed in PBS and bead-bound cells
were collected using a magnet and this step was repeated
four times. Bead-bound cells were resuspended in DMEM
with 20 % FBS.
Matrigel assay Matrigel (Trevigen BME) was thawed on ice
overnight and dispersed on 96-well plates (55 μl per plate)
and allowed to polymerize for 30 min at 37 °C. Lung ECs
were seeded on the Matrigel at the density of 5,000 cells per
well. Cells were incubated at 37 °C with 5 % CO2, and
images were taken 6 h later. ImageJ software was used to
determine total cellular cord length.
Scratch assay Lung ECs (6×104) were seeded on an Easy
Slide (Millipore) until the formation of a confluent mono-
layer. Cells were then starved in a serum-free medium for
12 h. Pipette tip (size of 200 μl) was used to scratch a straight
line across the middle of the cell monolayer. Cell debris was
washed off and cells with gap were incubated with 0.2 %
serum basal medium. Images were taken immediately after
scratch and the same images of the same fields were obtained
6 h later. The rate of cell migration was calculated as the
average percent wound closure from at least three indepen-
dent experiments using ImageJ software. In brief, images
were first converted to binary then threshold was adjusted
and cell-covered area was highlighted over background.
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Percentage of cell-covered area was then calculated and
denoted as percent wound closure. Serum deprivation-
induced cell death was assessed by trypan blue exclusion
assay. Endothelial cells were seeded in 24-well plates and
cultured in the serum-free medium for 6 h. Cell death was
then assessed by trypan blue staining.
Hypoxia assessment, blood perfusion measurement,
and vascular leakage study
Airway hypoxia was assessed by using HypoxiprobeTM-1,
following manufacturer’s protocol. Briefly, HypoxiprobeTM-
1 solution was injected at a dose of 60 mg/kg through
peritoneum, and trachea was harvested and frozen in OCT
30 min later. After sectioning, anti-pimonidazole antibody
was used to detect pimonidazole adducts which indicates
tissue hypoxia. Blood perfusion measurement was carried
out as we described [17]. Vascular leakage was analyzed
after intravenous injection of 100 μl of cy3-conjugated
microsphere (#R50) and 100 μl FITC-lectin at a concen-
tration of 1 mg/ml. Ten minutes later, mouse was perfused
with 1 % PFA in PBS. Trachea was then harvested for
whole-mount examination under confocal microscopy. The
intensity of extravasated microsphere was calculated as
described [18].
Quantitative real time RT-PCR
Tracheal samples were first incubated in RNAlater solution
(Invitrogen) overnight at 4 °C. Total RNAwas then isolated
using the QIAGEN Shredder and RNeasy Mini Kit
(QIAGEN) following the manufacturer’s protocol. Total
RNA (1 μg) was reverse transcribed with Moloney murine
leukemia virus reverse transcriptase (Invitrogen) and 5 μM
random hexamer primers according to the manufacturer’s
instructions. Two microliters of one to ten diluted reverse
transcription reactions was added to quantitative real time-
PCR with 5 μl of 2× SYBR Green Master Mix (Applied
Biosystems) and 100 nM forward and reverse primers spe-
cific for the genes of interest in a total volume of 10 μl.
Detection was carried out with the ABI Prism 7700 sequence
detector (Applied Biosystems). SDS analysis software (Ap-
plied Biosystems) was used to analyze the data. 18S mRNA
expression was used to normalize gene expression for
sample-to-sample variation in input and reverse transcription
efficiency. The 2–ΔΔCt method was used to calculate fold
changes. All primers used are shown in Supplemental
Table 1.
Tissue preparation and evaluation for fungal infection
All tracheal samples were placed in paraffin blocks and cut
longitudinally or transversely in 5 μm sections through the
entire tracheal segment. Grocott’s methenamine silver (GMS)
stain was used for each of these sections (Histotech laborato-
ries). The most severe section was scored for each tracheal
sample. Fungal infection was defined by the presence of
hyphal elements on GMS stain in the tracheal segment. The
degree of fungal burden was scored as follows: 0, no fungal
elements, 1 (minimal), fungal hyphae in less than 25 % of the
luminal area, 2 (mild) hyphae occluding 25 to 49 % of the
luminal area, 3 (moderate) hyphae 50 to 74 % of luminal area,
and 4 (severe) greater than 75 % occlusion of the luminal area
(Supplementary Fig. 3a). The depth of fungal invasion was
graded: 1 (minimal), invasion of the epithelial layer; 2 (mild),
invasion of the subepithelial layer; and 3 (moderate), invasion
to the depth of the cartilaginous tracheal ring (Supplementary
Fig. 3b).
Statistics
Statistical analysis was performed using two-tailed Student’s
t test, with a significance level of p<0.05. Semiquantitative
differences in fungal burden and depth of invasion were
evaluated by a nonparametric Kruskal–Wallis test.
Results
Tie2+ cell VHL haplodeficiency prolongs airway
microvascular perfusion and diminishes tissue hypoxia
The airway microcirculation is easily studied in major histo-
compatibility complex-mismatched orthotopic tracheal
transplants; these are functional allografts through which
the mouse breathes. This model system faithfully replicates
lymphocytic bronchitis, a large airway precursor of chronic
rejection (the bronchiolitis obliterans syndrome) [19]. We
previously showed that following alloimmune-induced air-
way microvascular injury and tissue hypoxia, recipient-
derived Tie2-expressing cells are recruited to donor trachea
and participate in vascular regeneration [10]. Upregulation of
HIF-1α promotes vascular reparative capacity of angiogenic
cells [14, 15]. Because VHL negatively regulates HIF-1α
protein levels, we hypothesized that downregulation of VHL
would promote vascular reparative capacity of Tie2-
expressing cells through upregulation of HIF-1α protein. To
examine the role of VHL expressed in Tie2+ cells in airway
microvascular repair, we conditionally knocked down VHL in
Tie2 lineage cells to establish heterozygosity, as homozygous
knockout results in embryonic lethality [20]. One allele VHL
knockdown has been shown to efficiently decrease VHL
protein expression in ECs [21]. Consistent with earlier find-
ings [22, 23], VHL-haplodeficient lung ECs from Tie2Cre(+)
VHL(fl/+) mice expressed higher levels of HIF-1α than ECs
from Tie2Cre(−)VHL(fl/+) mice (Supplementary Fig. 1).
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Tie2Cre(−)VHL(fl/+) recipients lost microvascular perfusion
in tracheal transplants at day 14 posttransplantation and partial
revascularization occurred by day 28, as determined by con-
focal fluorescence microscopy after intravenous injection of
FITC-lectin (Fig. 1a); early loss of perfusion is due to
alloimmune rejection and revascularization occurs because
of recipient-derived revascularization [10]. In contrast, trache-
as transplanted into VHL-haplodeficient recipients showed
significantly prolonged perfusion to day 18 posttransplanta-
tion and improved revascularization at day 28 (area perfused
∼40 vs. ∼20 %) (Fig. 1b). Laser Doppler flowmetry (LDF) is
another method of examining microvascular perfusion, pro-
viding a dynamic measurement of blood flow [17]. We dem-
onstrated that microvascular perfusion of tracheas
transplanted into VHL-haplodeficient mice was significantly
higher than control mice from day 12 to day 28 following
transplantation (Fig. 1c). Using pimonidazole staining to mea-
sure tissue hypoxia, we observed decreased tissue hypoxia in
tracheas transplanted into VHL-haplodeficient recipients at
both day 16 and day 28 posttransplantation (Fig. 1d). As Cre
expression in this Tie2-Cre strain may affect 25 % of bone
marrow cells [24], we also evaluated the possibility that
observed differences in airway perfusion were caused by
diminished VHL expression in cells of hematopoietic origin
participating in the alloimmune response. As CD4+ and CD8+
T lymphocytes have been previously demonstrated to mediate
vascular injury [25], we examined infiltration of these cells in
the tracheal allograft of VHL-haplodeficient and control ani-
mals. No significant differences were observed in the infiltra-
tion of CD4+ or CD8+ T cells in the donor tracheas (Supple-
mentary Fig. 2a). Moreover, no significant differences were
























































































Fig. 1 Recipient Tie2+ cell VHL haplodeficiency prolongs airway
microvascular perfusion and diminishes tissue hypoxia. a Confocal
microscopic FITC-lectin perfusion images showing microvascular per-
fusion of tracheas transplanted into control recipients with normal VHL
expression compared with recipients with VHL haplodeficiency in
Tie2+ cells. b Quantification of perfused airway microvasculature fol-
lowing transplantation (n=4–6). cAirway blood perfusion measured by
laser Doppler flowmetry in tracheas transplanted into recipients with or
without VHL haplodeficiency (n=4–6 per time point). d Pimonidazole
staining (green, red arrows) in transplanted airways in both day
16 and day 28 showing decreased hypoxia in grafts transplanted
into VHL-haplodeficient recipients. Scale bars, 100 μm (a and d).
Data are shown as means ± SEM. *P<0.05 at individual time points,
Student’s t test
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inflammatory chemokines (CXCL9, CXCL10, CXCL11,
CCL5, MCP-1, and IFN-γ) (Supplementary Fig. 2b). Togeth-
er these data suggest that the prolonged microvascular perfu-
sion of tracheal transplants in Tie2Cre(+)VHL(fl/+) recipients
likely resulted from accelerated vascular repair by VHL-
haplodeficient Tie2+ cells.
VHL-haplodeficient lung endothelial cells exhibit increased
angiogenic activity and enhanced resistance to serum
starvation-induced cell death
BMDACs with increased HIF-1α expression survive longer in
ischemic tissue and promote vascular repair in an ischemic hind
limb model [14, 15]. We hypothesized that increasing HIF-1α
expression through VHL knockdown would increase angio-
genic potency of Tie2+ cells displaying endothelial lineage.
Lung ECs were isolated and cultured for experiments between
passages 2 and 5. We first examined the effect of VHL loss on
EC migration, an essential process for angiogenesis. Scratch
assays showed that migration was markedly increased in
VHL-haplodeficient ECs when cultured in media con-
taining either 0.5 or 5 % FBS (Fig. 2a, b). EC culture
in Matrigel with media containing either 0.5 or 5 %
FBS revealed that VHL-haplodeficient cells exhibit sig-
nificantly increased cord formation (Fig. 2c, d). As the
capacity of EC survival in hypoxic tissue is essential for
neoangiogenesis and vascular repair, we then evaluated
the survival of VHL-haplodeficient ECs in serum deprivation
studies. Using a trypan blue assay to assess cell death,
we show that VHL-haplodeficient ECs were more resistant to
serum deprivation-induced cell death (Fig. 2e). From these
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Fig. 2 VHL-haplodeficient lung endothelial cells exhibit enhanced
angiogenic activity and increased resistance to serum deprivation-in-
duced cell death. a Migration of wild type (WT) and VHL-
haplodeficient (VHL+/−) lung EC was assessed by scratch wound
assay. Representative pictures were taken 6 h after scratch. b Percentage
of wound closure was quantified 6 h after scratch at culturing conditions
with 0.5 or 5 % FBS. c Network/capillary formation of WT and VHL-
haplodeficient ECs was assessed using a Matrigel assay. Representative
images were taken 6 h after culturing in 0.5 or 5 % FBS. d Quantifica-
tion of network formation as measured by total cellular cord length for
VHL-haplodeficient ECs in both 0.5 and 5 % FBS conditions. e Cell
death assessed by trypan blue assay. Experiments were performed three
times. Scale bars, 300 μm (a and c). Data are shown as means ±
SEM.*P<0.05; **P<0.01, Student’s t test
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angiogenesis by increasing EC survival, migration, and cord
formation.
VHL haplodeficiency increases angiogenic factor expression
in ischemic airways
Expression of angiogenic growth factors and cytokines are
closely associated with recruitment of circulating angiogenic
cells and are essential for neovascularization. Based on the
kinetics of microvascular perfusion of tracheas transplanted
into recipients with different levels of VHL expression,
mRNA was isolated from day 18 airway transplants, and
expression of angiogenic factors, cytokines, and angiogene-
sis associated receptors was analyzed by quantitative RT-
PCR. Expression of HIF-1α, SDF-1, and ANGPT1 was
significantly increased in airways transplanted into VHL-
haplodeficient recipients, but no significant differences in
expression of ANPGT2, VEGF, or PLGF were observed
(Fig. 3a). We then examined receptors commonly expressed
on reparative ECs. Expression level of Tie2 is significantly
higher in tracheas transplanted into VHL-haplodeficient re-
cipients; other receptors such as CXCR4 and VEGFR2 were
not significantly different between grafts transplanted into
control and VHL-haplodeficient recipients (Fig. 3b). These
data suggest that VHL knockdown in recipient Tie2 lineage
cells promoted donor vascular repair by increasing the spe-
cific expression of angiogenic factors and recruitment (or
survival) of vascular reparative cells.
VHL haplodeficiency improves microvascular function
and maturation
Tissue perfusion is determined not only by vessel density, but






























































































































Fig. 3 Analysis of angiogenic
cytokines and cognate
receptors. a Real time RT-PCR
analysis of angiogenic
cytokines of day 18 airways
transplanted into WT control or
VHL-haplodeficient recipients.
b Analysis of angiogenesis-
related receptors of day 18
airway allografts (n=4–6). Data
are shown as means ± SEM.
*P<0.05; **P<0.01, Student’s
t test
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Leakiness of microvessels results in extravasated plasma,
increased interstitial pressure, and compromised perfusion.
Tumor vessels formed by PHD2-deficient ECs are more nor-
malized compared with those formed by wild-type (WT) ECs
[16]. To evaluate microvascular permeability in VHL-
haplodeficient ECs compared with controls, we injected
Cy3-conjugated microspheres and FITC-conjugated lectin in-
to the circulatory system of animals under terminal anesthesia.
Microsphere extravasation was reduced by 50 % in airways
transplanted into VHL-haplodeficient recipients at day 28
posttransplantation (Fig. 4a, b). Coverage of ECs by pericytes
stabilizes vessels, and decreases plasma extravasation,
resulting in improved perfusion [26]. Double staining with
the EC marker CD31 and the mural cell (i.e., pericyte) marker
desmin revealed more desmin-expressing cells covering ves-
sels in grafts transplanted into VHL-haplodeficient recipients
(Fig. 4c). Further pericyte coverage quantification showed
about 30 % increase in grafts from VHL-haplodeficient
recipients (Fig. 4d). These structural studies indicate that
VHL haplodeficiency enhanced airway vascular perfusion
and alleviated tissue hypoxia in close association with im-
proved vascular integrity.
Diminished airway microvascular regeneration
and perfusion in Tie2+ cell HIF-1α knockout recipients
To more specifically determine whether vascular regeneration
of the tracheas was HIF-1α dependent, mice bearing HIF-1α
knockout Tie2 lineage cells (Tie2Cre(+)HIF1α(fl/fl)) and
Tie2Cre(−)HIF1α(fl/fl) controls were used as allograft
recipients. Airway graft perfusion in HIF-1α knockout in
Tie2Cre(+)HIF1α(fl/fl) recipient cells was decreased by
∼50 % at both day 16 and day 21 (Fig. 5a, b). Examination
of grafts by LDF confirmed decreased perfusion in tracheas
transplanted into HIF-1α-deficient recipients (Fig. 5c). These



























































































Fig. 4 Improved vessel function and maturation in airways transplanted
into recipients with Tie2+ cell VHL haplodeficiency. a Representative
confocal images showing extravasated 50 nm microsphere (red) and
microvascular perfusion (green) in normal airways and airways
transplanted into control or VHL-haplodeficient recipients at day 28. b
Quantification of microsphere extravasation (n=4–6). c CD31 (marker
for ECs) and desmin (marker for pericytes) staining showed more com-
plete pericyte-covered vessels in airways transplanted into VHL-
haplodeficient recipients at day 28. d Quantification of pericyte coverage
in the microvasculature of transplanted airways (n=3–5). Scale bars,
100 μm (a), 20 μM (c). Data are shown as means ± SEM, *P<0.05,
Student’s t test
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required for effective repair of airway microvasculature fol-
lowing allorejection-induced damage.
Tie2+ cell VHL haplodeficiency attenuates allograft invasion
by A. fumigatus
To evaluate the translational impact of VHL haplodeficiency-
associated increased tissue perfusion, we compared Tie2Cre(−)
VHL(fl/+) and Tie2Cre(+)VHL(fl/+) mice, using a standard
Aspergillus tracheal infection assay. Mice were infected at day
16 posttransplantation and evaluated at day 18 for histopatho-
logical differences using GMS stain to detect fungi. Fungal
burden and depth of invasionwere graded on a semiquantitative
scale (Supplementary Fig. 3a, fungal burden (0–4 scale), and
Supplementary Fig. 3b, depth of fungal invasion (0–3 scale)).
Allografts were evaluated with longitudinal or transverse
sections (5-μm thickness) through the entire depth of
the tracheal sample. On average, 420 transverse sections
or 180 longitudinal sections were evaluated per tracheal sam-
ple. For each allograft, the section with the highest fungal
burden or depth of invasion was used for scoring. Fungal
burden was similar between Tie2Cre(+)VHL(fl/+) and
Tie2Cre(−)VHL(fl/+) mice (mean fungal burden score, 2.8
and 3.2, respectively, P=0.5) (Fig. 6a). In contrast, the degree
of A. fumigatus invasion was significantly lower in VHL-
haplodeficient recipients compared to control mice (mean
depth of fungal invasion score, 0.3 and 1.9, respectively,
P=0.04) (Fig, 6b). In 83 % (5/6) of the VHL-haplodeficient
mice, A. fumigatus was noninvasive (depth of fungal invasion
grade 0) (Fig. 6c), whereas in the control mice, 75 % (6/8)
showed a grade 2 (to subepithelial layer) or greater depth of
invasion (Fig. 6d, e).
Discussion
We previously showed that recipient-derived Tie2+ cells are
essential in the repair of damaged airway microvasculature
following transplantation [10]. In the current study, we dem-
onstrated that airway microvascular regeneration is promot-
ed by VHL knockdown in Tie2 lineage cells. Microvascular
perfusion is significantly prolonged in tracheas transplanted
into recipients that are VHL-haplodeficient in Tie2 lineage
cells. Although we cannot rule out the effect of VHL-
haplodeficient hematopoietic cells, expression of common
immune response- and inflammation-induced cytokines was
not significantly altered in VHL-haplodeficient recipients,





































































recipient with HIF-1α knockout
in Tie2 lineage cells. a
Representative FITC-lectin
microvascular perfusion images




6). c Laser Doppler flowmetry
analysis showing relative
perfusion of tracheal transplants
(n=4–6 per time point). Scale
bar, 100 μm (a). Data are shown
as means ± SEM. *P<0.05,
Student’s t test
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resulted from accelerated vascular repair and not from di-
minished alloimmune response-induced vascular damage.
To examine whether improved vascular regeneration was
associated with enhanced reparative ability of recipient-
derived ECs, we demonstrated that VHL-haplodeficient lung
ECs exhibited enhanced migration, increased capability of
cord formation, and resistance to serum starvation-induced
cell death, suggesting that these cells may have a survival
advantage in the hypoxic microenvironment of the rejecting
airway. Therefore, VHL haplodeficiency may increase air-
way microvascular repair by enhancing the angiogenic ac-
tivity of ECs. It is not known whether VHL expression levels
affect the function of TEMs, but as a subgroup of BMDACs,























































































Fig. 6 Tie2+ cell VHL haplodeficiency attenuates A. fumigatus inva-
sion. All animals were infected with A. fumigatus on posttransplant day
16 and euthanized on day 18. A semiquantitative scoring system was
used to grade the degree of fungal burden (0–4 scale, Supplementary
Fig. 3a) and depth of fungal invasion (0–3 scale, Supplementary Fig. 3-
b). On average, 420 transverse sections or 180 longitudinal sections
were evaluated and the section with the highest grade was used for
scoring. a Degree of fungal burden, as measured on a semiquantitative
scale 0–4, by VHL expression status (n=6). bDepth of fungal invasion,
as measured on a semiquantitative scale by VHL expression status.
Mean depth of invasion increased in control compared with VHL-
haplodeficient mice (n=8). Representative GMS sections of fungal
invasion (n=14) (c–e). c Longitudinal section of A. fumigatus-infected
VHL-haplodeficient animal, displaying a high degree of fungal burden
(grade 3) without evidence of epithelial invasion (grade 0) (10× mag-
nification), inset (100× magnification). d Transverse section of A.
fumigatus-infected control animal with invasion to the depth of the
subepithelial layer (grade 2) (10× magnification), inset (100× magnifi-
cation). e Longitudinal section of A. fumigatus-infected control animal
with invasion to the depth of the cartilaginous ring (grade 3) (10×
magnification), inset (40× magnification). C denotes cartilaginous ring,
E specifies epithelial layer, SE specifies subepithelial layer, TL denotes
tracheal lumen (n=6–8 animals/group). Red arrows denote fungal
hyphae in lower magnification images. Data are shown as means ±
SEM. *P<0.05, nonparametric Kruskal–Wallis test
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metabolism and augment their survival in an ischemic envi-
ronment, as has been suggested [15].
Production of angiogenic factors in an ischemic microen-
vironment is associated with microvascular regeneration. We
observed an increased expression of the angiogenic factor,
SDF-1, in airways transplanted into recipients with VHL
haplodeficiency. SDF-1 is a HIF-1 target gene product that
is essential for the recruitment of CXCR4-expressing
proangiogenic cells [10, 27]. Although CXCR4 and
VEGFR2 expressions were not significantly different in
airways transplanted into control and VHL-haplodeficient
recipients, Tie2 expression was ∼2-fold higher in airways
transplanted into VHL-haplodeficient recipients. These data
suggest that VHL haplodeficiency increases the expression
of angiogenic factors, promoting recruitment and retention
of angiogenic cells, and thus may establish a positive feed-
back loop to promote vascular repair.
In tracheas transplanted into VHL-haplodeficient recipi-
ents, we also showed a significant increase in ANGPT1 ex-
pression. ANGPT1 prevents the formation of the intercellular
gaps in the endothelium, stabilizing the vasculature and
protecting against leakage [28–30]. Although not required in
quiescent mature vasculature, ANGPT1 functions as a protec-
tive factor, regulating responses to tissue injury and microvas-
cular disease in diabetes [31]. In contrast, expression of
ANGPT2weakens endothelial–pericyte interactions, resulting
in pericyte loss and vascular instability [32, 33]. It was recent-
ly shown that in conditions characterized by sustained inflam-
mation, pericyte investment of the endothelium was required
for the anti-leak actions of ANGPT1 [18]. Congruent with our
findings for ANGPT1 in VHL-haplodeficient recipients, we
also showed that regenerated vessels are less leaky and have
more pericyte coverage. Together our data suggest that VHL
haplodeficiency may increase vascular stability by regulating
the expression levels of ANGPT1 and downstream signaling
pathways, which stabilizes the vasculature through augmen-
tation of mural cell coverage.
In recipients with HIF-1α knockout in Tie2 lineage cells,
we demonstrated that microvascular repair is significantly
diminished, suggesting that HIF-1α expressed in Tie2+ cells
is essential for repair of damaged microvasculature follow-
ing alloimmune rejection. This finding is consistent with the
previously established concepts that: (a) HIF-1 plays an
essential role in vascular remodeling [34]; (b) EC HIF-1α
deficiency decreases cardiac capillary density following
pressure overload [35]; and (c) HIF-1 deficiency impairs
burn wound vascularization and homing of BMDACs [36].
We cannot rule out the possibility that EC-expressed HIF-2α
also may have contributed to airway microvascular repair
and regeneration associated with VHL haplodeficiency. In
fact, EC HIF-2α has been associated with increased vascular
stability in tumor xenograft microvasculature [16] and plays
an important role in revascularization in limb ischemia and
autochthonous skin tumor models [37]. Nevertheless, from
our results, it is clear that loss of HIF-1α alone in recipient
Tie2+ cells was sufficient to significantly increase the dura-
tion of ischemia associated with allograft rejection.
Finally, we demonstrate that VHL haplodeficiency de-
creased the depth of A. fumigatus graft invasion when com-
pared with infected WT controls, suggesting another thera-
peutic role for modulating HIF in lung transplant recipients.
Although A. fumigatus is a facultative aerobe, it has the
capacity to thrive in hypoxic conditions, an adaptation that
may be critical for the mold’s pathogenicity [38–41]. As A.
fumigatus naturally grows in decaying organic matter, it is
not surprising that improving microvascular perfusion and
tissue health may lessen the invasive nature of the pathogen.
Alternatively, increased expression of HIF-1α may itself
play a role in decreasing A. fumigatus invasion. Although
the role of HIF in fungal pathogenesis is not well described,
HIF plays a key role in mitigating bacterial pathogenesis
[42, 43]. For instance, the downregulation of HIF-1α by
Chlamydia is thought to provide a virulence advantage for
the organism [43]. Another possibility is that VHL-
haplodeficient and control recipients differed in their im-
mune response to the fungus. However, as the two demon-
strated baseline similarity in their expression of immune and
inflammation-induced cytokines (Supplementary Fig. 2),
differences in the immune response are not likely to account
for the observed differences in fungal virulence. It is also
notable that the degree of fungal burden was similar in VHL
haplodeficient and WT control mice (Fig. 6a). Thus, the
observed effect was likely a result of mitigating the patho-
gen’s interaction with the host rather than lowering fungal
burden, as might be observed with the use of antifungal
agents.
In summary, we showed that the increased expression of
HIF-1α in recipient Tie2 lineage cells through VHL knock-
down promotes microvascular repair of tracheal allografts,
which in turn leads to enhanced perfusion. VHL knockdown
promotes vascular repair through several mechanisms,
which include: enhancing the activity of angiogenic cells,
as well as their recruitment, retention, and survival; increas-
ing the expression of angiogenic growth factors; and stabi-
lizing regenerated vessels. Moreover, we demonstrate the
translational relevance of the current work by focusing on
two factors associated with chronic rejection: ischemia and
infection. Higher expression of HIF-1α in the transplant
recipient promotes microvessel integrity and may play an
important role in modulating the host–pathogen interaction
for A. fumigatus, a common pathogen and major clinical risk
factor for the development of OB in lung transplant recipi-
ents [44, 45]. This work complements our prior study [10]
showing that enhanced HIF-1α in donor tissue also facili-
tates vascular healing, suggesting that treatment of both graft
and recipient with drug or gene therapy to induce HIF-1
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might be clinically beneficial. The actions of HIF-1α are
pleiotropic, and its actions contribute to both the promotion
and resolution of inflammation in biological processes [46].
Additionally, HIF-1α appears to exert multiple protective
functions on mucosal surfaces (e.g., regulating defensins
[47]). Given that the aging process impedes normal angio-
genic cell mobilization and can be restored through the
enhancement of HIF-1 activity [48], augmenting HIF-1α
activity may be particularly effective for preventing chronic
rejection in elderly transplant recipients. In summary, this
study suggests that targeting recipient-derived angiogenic
cells may have value as a therapeutic approach for
preventing chronic rejection through increasing airway mi-
crocirculation and modulating the pathogenicity of OB-
inducing microorganisms.
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